Cineplex Inc.: Is This Great Stock Worth the Inflated Price?

There are a lot of reasons to like Cineplex Inc. (TSX:CGX). The valuation is not one.

| More on:
The Motley Fool

There’s a lot to like about Cineplex Inc. (TSX:CGX).

Billionaire investor Warren Buffett tells investors to look for a moat–a sustainable competitive advantage–when finding investment opportunities. Ask yourself this: If I spent the company’s enterprise value trying to destroy it, could I do it? If the answer is anything but a definite no, it’s time to move on.

Cineplex has a massive moat. It essentially owns the movie theatre business in Canada, commanding a 78% share of the box office in this country in 2015. Its largest competitor, privately held Landmark Cinemas, has just a 9% market share. A number of smaller competitors split the remaining 13%.

It’s common knowledge that theatres don’t make much on ticket sales with most of the gross going back to the movie studios. Profits come from the concession stand.

Cineplex has long since moved past selling bags of popcorn. The company’s theatres have evolved into full-fledged entertainment destinations, featuring such things as full-service restaurants, arcades, and screens showing alternative programming. The company also makes additional revenue from selling premium experiences–think IMAX and Ultra AVX screens–digital signage for other companies, and through its SCENE debit and credit card partnership with Bank of Nova Scotia.

In short, Cineplex has done a terrific job leveraging the low-margin business of showing movies into all sorts of lucrative divisions.

The problem

The problem isn’t with Cineplex itself. Management has done a terrific job.

The problem is valuation.

Cineplex shares are currently flirting with the $50 level, which is right around its all-time high. That’s a far cry from where shares were five years ago when they traded at less than $25 each. That’s a total return of more than 113% during that time, excluding dividends.

Investors are obviously willing to pay up for a company with such great growth. In 2015 the company earned $134 million on sales of $1.37 billion, good enough for $2.12 per share. That’s a nice improvement over 2014 when it earned $1.20 per share on sales of $1.23 billion.

But those earnings were perhaps artificially propped up by the new Star Wars movie, which came out late in the fourth quarter. Analysts predict earnings will take a step back in 2016, coming in at $1.98 per share, and 2017 is projected to be much better with earnings at $2.37 per share.

At $50 per share, that puts Cineplex at 25 times 2016’s earnings and 21 times 2017’s projected bottom line. That’s expensive no matter how you slice it.

Things continue to get discouraging when we look at other valuation metrics. For 2015, the company generated just $97 million in free cash flow. That puts the company at more than 32 times free cash flow. Additionally, the company only barely earned enough to cover its 3.1% dividend, at least from a free cash flow perspective.

The issue with paying an aggressive valuation is simple. If the company hits the growth targets the market sets out for it, everything is fine. But if it doesn’t, there’s significant downside potential.

If Cineplex loses its lustre and investors only assign it a 20 times earnings valuation–which is still more expensive than the market as a whole–it’ll trade at approximately $40 per share. That’s a 20% haircut from today.

For shares to go higher, one of two things have to happen. Either earnings have to grow faster than expected or the company’s multiple has to expand. And 25 times earnings is already expensive, so that leaves greater-than-predicted earnings growth. That could happen, but what if it doesn’t?

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Nelson Smith has no position in any stocks mentioned.

More on Dividend Stocks

Two seniors float in a pool.
Dividend Stocks

TFSA: How to Earn $1,890 in Annual Tax-Free Income

Plunk these investments into your TFSA to earn passive income and avoid the taxman.

Read more »

Engineers walk through a facility.
Dividend Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

AtkinsRéalis (TSX:ATRL) is one TSX stock I'd never invest in.

Read more »

edit Woman in skates works on laptop
Dividend Stocks

3 No-Brainer Stocks to Buy Under $30

These three stocks all offer a huge deal for investors looking for dividends, as well as growth that will last.

Read more »

You Should Know This
Dividend Stocks

How to Convert a $300 Monthly Investment Into $338 in Monthly Income

If you want a certain amount in monthly passive income, invest a similar amount today and leave the rest to…

Read more »

Increasing yield
Dividend Stocks

3 Income Stocks With Big Yields to Consider in April 2024

If you haven’t yet made your March investments, here are three income stocks to buy the dip and lock in…

Read more »

Senior Man Sitting On Sofa At Home With Pet Labrador Dog
Dividend Stocks

RRSP Investors: Don’t Miss Out on This Contribution Hack!

This hack has so many benefits for you -- not just when you put it in your RRSP but for…

Read more »

A red umbrella stands higher than a crowd of black umbrellas.
Dividend Stocks

Passive Income: 2 Safe Dividend Stocks to Own for the Next 10 Years

Dividend stocks such as Manulife and Fortis can help you generate a stable and recurring passive-income stream.

Read more »

Young woman sat at laptop by a window
Dividend Stocks

3 Dividend Stocks Everyone Should Own for the Long Haul

For investors looking for top-tier dividend stocks to buy and hold for the long term, here are three of my…

Read more »